Objectives: To compare and characterize extended-spectrum b-lactamase (ESBL)-producing Escherichia coli from pigsties, pig farmers and their families on farms with previous high or no use of third-or fourth-generation cephalosporins.
Introduction
Extended-spectrum b-lactamase (ESBL)-producing bacteria are emerging worldwide in both humans and animals. The use of third-and fourth-generation cephalosporins in food animal production leads to ESBL-producing Escherichia coli among foodproducing animals and several studies have detected ESBLproducing E. coli in production animals. 1 -5 Studies from the Netherlands found clonally related ESBLproducing E. coli and similar plasmids in broilers, broiler meat and humans, suggesting broiler meat as a source of ESBLproducing E. coli causing infection in humans. 2 Dierikx et al. 6 detected ESBL genes on plasmids in E. coli from broilers at farm level that were identical to those in E. coli from the corresponding farmer. Moodley and Guardabassi 7 detected transfer of IncN plasmids with bla CTX-M-1 between Danish pigs and pig farmers.
Andersen et al. investigated the effect of third-and fourthgeneration cephalosporin use on the occurrence of extendedspectrum cephalosporinase-producing E. coli in Danish pig farms; they showed that previous regular use of third-or fourth-generation # The Author 2014. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com J Antimicrob Chemother 2014; 69: 2650 -2657 doi:10.1093/jac/dku180 Advance Access publication 7 June 2014 cephalosporins was a significant risk factor for the occurrence of cephalosporinase-producing E. coli in pigs in Denmark (V. D. Andersen, V. F. Jensen, H. Vigre, M. Andreasen and Y. Agersø, unpublished results). In the present study cephalosporinase-producing E. coli from pigs found in the study by Andersen et al. were characterized by ESBL genotype, PFGE, susceptibility to non-b-lactam antibiotics and phylotype, and selected isolates were characterized by multilocus sequence typing (MLST).
The aim of this study was to compare and characterize ESBL-producing E. coli from pigsties, pig farmers and their families from farms with previous high or no use of thirdor fourth-generation cephalosporins, to investigate whether ESBL-producing E. coli or plasmids with ESBL genes have spread between pigs and humans.
Methods

Study design
A cross-sectional study of ESBL-producing E. coli on Danish pig production farms stratified by previous consumption levels of third-or fourthgeneration cephalosporin was conducted between November 2010 and May 2011. The study was started after the voluntary stoppage of thirdand fourth-generation cephalosporin use for pigs in July 2010. 8 Therefore, the stratification was based on the consumption level 1 year before the study was started. Medium to large integrated pig herds were selected based on information from the Danish Central Husbandry Register (CHR) and two groups were selected based on the number of prescribed third-or fourth-generation cephalosporins within a year. These groups comprised 20 herds with no third-or fourth-generation cephalosporin use and 19 herds with frequent use (V. D. Andersen, V. F. Jensen, H. Vigre, M. Andreasen and Y. Agersø, unpublished results). Individuals working and living on farms were asked to participate after receiving full information from the investigators. Written informed consent was obtained from all participants who were ≥18 years of age, and proxy written informed consent for participants aged ,18 years was obtained from parents or legal guardians. The volunteers signed an informed consent form and were asked to agree to faecal swabbing and to answer a standard questionnaire (available as Supplementary data at JAC Online), which was designed to collect demographic data and epidemiological risk factors for carriage of ESBL-producing bacteria, including gender, age, medications, livestock exposure, handling of antibiotics for pigs, travel activities, meat consumption and previous occupation. A total of 195 individuals from 19 farms with high-level third-or fourth-generation cephalosporin consumption and 20 farms with no consumption volunteered to participate. The questionnaire was originally in Danish, but has been translated into English for this publication. 
Description of sampling
On each farm 15 stool samples were collected from different pens in each of the following sections: sows/piglets, weaners and finishers. The stool samples were sent to the Technical University of Denmark and analysed for cephalosporinase-producing E. coli within 24 h as described by Agersø et al. 9 In brief, 1 g of pooled sample was added to 10 mL of MacConkey broth supplemented with ceftriaxone (1 mg/L), and incubated overnight at 448C. A 10 mL sample of the culture was streaked onto MacConkey agar plates with added ceftriaxone (1 mg/L) and incubated overnight at 448C. From the agar plates, three presumptive colonies of cephalosporinase-producing organisms were selected and re-streaked.
Detection of ESBL-producing E. coli in human faecal samples Farmers, employees and residents at the farms were asked to complete a questionnaire and send a rectal swab sample (Copan, Brescia, Italy) to Statens Serum Institut at the same time as the stool samples from the pigsties were sampled. The swabs were analysed within 24 h.
The human faeces from the swabs were spread on Discovery agar plates (Oxoid, Basingstoke, UK) with 1 mg/L ceftriaxone and incubated at 358C for 18 h. Presumptive ESBL-producing E. coli were subcultured on 5% blood agar plates (SSI Diagnostika). Three colonies per sample were investigated further. The isolates were identified with API 20E (bioMérieux, Marcy-l'Étoile, France).
Molecular and phenotypic characterization of ESBL-producing E. coli
Three ESBL-producing E. coli isolates obtained from each human sample and one ESBL-producing E. coli isolate from each positive pooled sample obtained from the pigsties were further characterized.
The isolates were screened for bla CTX-M by PCR. If negative, the isolates were further screened for bla SHV and bla TEM by PCR as previously described. 10 -13 Positive control strains were E. coli O:149 77-30108-11 (bla CTX-M ), E. coli 76-33094-7 (bla TEM ) and Salmonella Keurmassar DAK-2 (bla SHV ). Positive amplicons were sequenced.
The isolates were phylotyped by multiplex PCR and classified as phylogroup A, phylogroup B1, phylogroup B2, phylogroup D or non-typeable as previously described by Clermont et al.
14 PFGE was performed with XbaI as a restriction enzyme according to Tenover et al. 15 The genetic profiles were compared using BioNumerics version 6.6 (Applied Maths, Sint-Martens-Latem, Belgium). PFGE types were defined with a cut-off value of 90% homology for relatedness.
MICs were determined for 12 non-b-lactam antimicrobial agents by the use of Sensititre panels (Trek Diagnostic Systems Ltd, East Grinstead, UK). Results for chloramphenicol, ciprofloxacin, gentamicin and trimethoprim were interpreted according to EUCAST clinical breakpoints (http:// www.eucast.org), whereas results for apramycin, florfenicol, neomycin, and spectinomycin were interpreted according to the EUCAST MIC epidemiological cut-off value, and results for nalidixic acid, tetracycline, streptomycin and sulfamethoxazole were interpreted according to CLSI standards.
16 E. coli ATCC 25922 was used for quality control.
MLST
For each representative PFGE cluster type, one isolate was chosen for MLST. In cases where the same PFGE cluster type was detected in both pigs and humans, both isolates were typed by MLST. MLST was performed using seven conserved housekeeping genes (adk, fumC, gyrB, icd, mdh, purA and recA) (http://mlst.warwick.ac.uk/mlst/).
Conjugative transfer and characterization of plasmid replicons
All ESBL-producing E. coli with bla CTX-M-1 belonging to different PFGE cluster types were used as donors in filter mating experiments. In cases where the same PFGE cluster type was detected in both pigs and humans, both isolates were used as donor; in total 51 isolates were used in these experiments. The donor and recipient (E. coli 1005RN, rif R , nal R ) were grown in brain heart infusion broth overnight at 378C. Donor and recipient broths were mixed 1 :1 and 500 mL of the mixture was added to a 0.45 mm filter ESBL-producing E. coli from Danish pigs and pig farmers 2651 JAC (EMD Millipore Corporation, Billerica, MA, USA) placed on a 5% blood agar plate and the plates were incubated overnight at 378C. The filter was transferred to 10 mL of 0.9% NaCl and vortex mixed. Transconjugants were selected on brain heart infusion agar supplemented with 1 mg/L ceftriaxone and 100 mg/L rifampicin. The presence of bla CTX-M-1 in the transconjugants was tested and confirmed by PCR. 12 If no transconjugants were obtained or if more than one replicon was found in the transconjugant, plasmid purification was performed. Afterwards, plasmids were introduced to electrocompetent plasmid-free E. coli Invitrogen ElectrMax TM DH10B TM cells by means of transformation by electroporation. 17 PCR-based replicon typing (PBRT) was used to characterize plasmids from the ESBL-producing E. coli with bla CTX-M-1 chosen for mating experiments and the isolates were tested for the following incompatibility groups by single PCRs: IncI1, IncN, IncA/C, IncHI2, IncK and IncF. 18 
Statistical analysis
Statistical significance tests of differences between proportions of samples positive for ESBL-producing E. coli were performed using the x 2 test or Fisher's exact test (two-tailed) when the number of positive samples was low (less than five) (GraphPad Prism software, version 5, GraphPad, La Jolla, CA, USA).
Results
Detection of ESBL-producing E. coli in pigs
At 15 of the 19 (79%) farms with a high consumption of cephalosporins at least one of the tested stool samples from pigs tested positive for ESBL-producing E. coli. This occurrence was significantly (P ¼ 0.0004) higher compared with farms with no consumption of third-or fourth-generation cephalosporins, where 4 out of 20 (20%) farms had pigs with ESBL-producing E. coli. In all farms with pig samples positive for ESBL-producing E. coli, positive samples were found among the stool samples from sows/piglets. Some of these farms also had ESBL-producing E. coli in samples from weaning pigs or finisher pigs (data not shown). In total, 13 out of 177 stool samples from pig farms with no consumption of cephalosporins and 50 out of 162 stool samples from farms with high consumption of cephalosporins were positive for ESBL-producing E. coli. The detected genes encoding ESBL production in the isolates from pigs were bla CTX-M-1 (14 farms), bla CTX-M-14 (2 farms), bla SHV-12 (1 farm) and bla CTX-M-97 (2 farms) [ Figure 1 , Table 1 and Table S1 (available as Supplementary data at JAC Online)].
Detection of ESBL-producing E. coli in humans
A total of 195 persons participated in the study. The number of participants at each farm varied from 2 to 10. Of the 195 persons, 136 had direct contact with pigs (data not shown).
ESBL-producing E. coli was detected in 19 of the 195 participants (Table 2 and Table S1 ). Unfortunately, not all questionnaires were filled completely, most likely because the questionnaire was in Danish and nine persons with ESBL-producing E. coli originated from other countries and might not have possessed Danish literacy. The 19 persons were from 13 of the 39 investigated farms ( Figure 1 , Table 2 and Table S1 ). From each of the 13 farms, one or two persons were carrying ESBL-producing E. coli (Table 2 and  Table S1 ). All but one of the humans with ESBL-producing E. coli had contact with pigs, 14 were from farms with previous high use of third-or fourth-generation cephalosporins and 5 were from farms with no previous use ( Table 2) . Persons with direct contact with pigs (15/72; 21%) more often had ESBL-producing E. coli in their stools if ESBL-producing E. coli was detected in the pigsties, compared with persons with contact with pigs (3/64; 5%) if no ESBL-producing E. coli was detected in the pigsties (P ¼ 0.0056) (data not shown).
Phylotyping
One of the tested isolates from pigs belonged to phylogroup B2 and three isolates belonged to phylogroup D, all other pig isolates belonged to phylogroup A (n¼ 26) or B1 (n¼ 17) or were non-typeable (n¼ 16). Six isolates from two humans belonged to phylogroup B2 and three isolates from another human belonged to phylogroup D, whereas all other isolates from humans belonged to phylogroup A (n ¼ 25) or B1 (n ¼ 12) or were nontypeable (n¼ 11) (Table S1 ).
Antimicrobial susceptibility testing
All but seven ESBL-producing E. coli isolates from pigs were resistant to more than two of the tested non-b-lactam antibiotics. Three of the human isolates were susceptible to all tested non-b-lactam antibiotics, one isolate was only co-resistant to sulfamethoxazole, and one isolate was only co-resistant to trimethoprim. All other ESBL-producing E. coli isolates from humans were resistant to two or more of the tested antibiotics (Table S1) .
PFGE
In total, 33 PFGE cluster types were identified whilst 32 isolates had a unique PFGE type (Table 1 and Table S1 ).
MLST
Several different sequence types (STs) were detected in both humans and pigs, including 11 new STs (Table 1 and  Table S1 ). Isolates belonging to ST10 were detected at eight farms, and these included isolates from both humans and pigs (Table S1 ). Isolates from two humans belonged to B2/ST131 (Table 1 and Table S1 ).
bla CTX-M-1 plasmid transfer
Plasmid transfer by conjugation was possible for 44 of the 51 tested E. coli isolates with bla CTX-M-1 (Table S1 ). The investigated plasmids belonged to IncI1, IncF and IncN (Table 1 and  Table S1 ). At seven farms the same Inc plasmid type was detected in CTX-M-1-producing E. coli transconjugants from both humans and pigs (Table 1 and Table S1 ). The isolates from two of the seven farms (farms 29 and 84) belonged to the same PFGE type/MLST type. The CTX-M-1-producing E. coli transconjugants from humans and pigs from the remaining five farms (1, 17, 31, 38 and 46) where the same Inc plasmid type was detected in both humans and pig isolates did not belong to the same clone type according to PFGE and MLST (Table 1 and Table S1 ).
Comparison of ESBL-producing isolates from pigs and humans
On 10 farms the same ESBL gene was detected in both pig stools and human faeces (Figure 1 , Table 1, Table 2 and Table S1 ). The Hammerum et al.
genes found in both humans and pig stool samples were bla CTX-M-1 (eight farms), bla CTX-M-14 (one farm) and bla SHV-12 (one farm) (Figure 1 , Table 1, Table 2 and Table S1 ). In one case, ST34 CTX-M-1-producing E. coli was found in the stool samples from pigs and in the faecal sample from the farmer (46-P3), whereas his wife (46-P2) was carrying an ST131 CTX-M-27-producing E. coli. She worked as an office assistant, ate meat and had been in contact with a cat, but no other animals ( Table 2) . In three farms, ESBL-producing E. coli was detected in humans but not in pig stool samples (Figure 1 , Table 1 and Table S1 ). The genes encoding ESBL in these isolates were bla CTX-M-1 , bla CTX-M-24 and bla CTX-M-97 , respectively ( Figure 1 , Table 1 and  Table S1 ). All three farms did not use third-or fourth-generation cephalosporins. ESBL-producing E. coli from Danish pigs and pig farmers 2653 JAC ESBL-producing E. coli isolates with the same ESBL type, phylotype, MLST type and PFGE type from both pigs and humans at the farm level were detected at four farms (Table 1 and Table S1 ). The involved persons had all been in contact with pigs.
Discussion
The study by Andersen et al. showed that previous use of third-or fourth-generation cephalosporins selects for cephalosporinaseproducing E. coli in pigs (V. D. Andersen, V. F. Jensen, H. Vigre, M. Andreasen and Y. Agersø, unpublished results).
In our study, ESBL-producing E. coli isolates with the same CTX-M enzyme, phylotype, PFGE type and MLST type were detected in both pigs and in humans with contact with pigs, indicating transfer of ESBL-producing E. coli between pigs and humans.
In July 2010, a voluntary ban on cephalosporins was started in Danish pig production. This led to a significant reduction in the occurrence of extended-spectrum cephalosporinase-producing E. coli in slaughter pigs. 8 So it seems likely that the pig reservoir of ESBL-producing E. coli can be reduced both in Denmark and elsewhere if pigs are not treated with cephalosporins, and by this means the possible transfer of ESBL-producing E. coli from pigs to farmers can also be reduced.
In our study ESBL-producing E. coli was detected in 5% of the humans with contact with pigs that tested negative for ESBL-producing E. coli. This corresponded to the findings on ESBL-producing E. coli from Danish army recruits. 19 In both cases another community source, such as food or contact with ESBL carriers in the community, seems likely.
Rodríguez-Bañ o et al. 20 showed that the prevalence of faecal carriage of ESBL-producing E. coli was higher in relatives of patients with a urinary tract infection with ESBL-producing E. coli than in unrelated persons. This could be explained by person-to-person transmission or acquisition from a common source, probably related to food. 20 Transfer of ESBL-producing E. coli from farmers working with pigs to family members not working with pigs was not detected in our study. Only in one case did a family member test positive for ESBL-producing E. coli, but since the farmer was carrying an ST34 CTX-M-1-producing E. coli, whereas his wife was carrying an ST131 CTX-M-27-producing E. coli, person-to-person transmission does not seem likely.
In the present study CTX-M-1-producing E. coli was the most prevalent ESBL enzyme detected. This corresponds to findings from the Danish integrated surveillance programme (DANMAP), where CTX-M-1 was the most common ESBL enzyme among ESBL-producing E. coli in Danish pigs both at farm level and at slaughter.
8 CTX-M-1 was also the most common ESBL enzyme detected in pigs from Spain and Portugal. 21, 22 Transfer of bla CTX-M-1 by conjugation was possible for 44 of the 51 tested isolates. The same Inc plasmid types were detected in isolates from both humans and pigs at seven farms. This could indicate horizontal plasmid transfer between humans and pigs besides clonal spread. To investigate this further, plasmids have to be typed either by plasmid MLST or RFLP. Highly similar IncN plasmids carrying bla CTX-M-1 have previously been detected in Danish pigs and pig farmers. SHV-12-producing E. coli and CTX-M-14-producing E. coli were also detected in our study from both pigs and humans. Both enzymes have been detected in pigs from Denmark, Korea, Spain and Portugal. 21 -23 Furthermore, CTX-M-14-producing E. coli has been detected in Danish army recruits, indicating a community source for this enzyme. 19 CTX-M-97-producing E. coli was detected in both humans and pigs. To our knowledge, CTX-M-97-producing E. coli has been detected only in a patient previously and not in pigs (submitted by J. Hacker to http://mlst.warwick.ac.uk/mlst/).
CTX-M-24-producing E. coli was detected in a farmer on a farm where ESBL-producing E. coli was not detected in pig stool samples. The origin of the CTX-M-24-producing E. coli is unknown. The farmer had, besides pigs, been in contact with a dog and a cat. CTX-M-24-producing E. coli has previously been detected in dogs. 24 The office assistant with no contact with pigs was carrying B2-ST131 CTX-M-27-producing E. coli. The origin of the isolate was unknown, but B2-ST131 CTX-M-27-producing E. coli has been detected from Danish patients. 25, 26 CTX-M-27 has, to our knowledge, not been detected in E. coli from Danish animals, but in E. coli from pigs and poultry in China. 27 Most isolates from both pigs and humans in our study were resistant to two or more of the tested antibiotics besides b-lactams, which defines them as multidrug resistant. The resistance to non-b-lactams included antibiotics that are used for treatment of E. coli infections in humans (e.g. sulphonamides, ciprofloxacin and gentamicin).
UTIs are most often associated with phylogroup B2 and, to some extent, phylogroup D. 28 In our study B2 and D were not very common; only isolates from two humans and one of the pigs belonged to B2 and one isolate from one pig and one human belonged to D.
CTX-M-15 is the predominant enzyme among ESBL-producing E. coli in both urine and bloodstream infections in Denmark, while the enzymes detected in the present study (CTX-M-1, CTX-M-14 and CTX-M-27) are less common.
29 CTX-M-15-producing E. coli Pigs and humans Figure 1 . Occurrence of ESBL-producing E. coli at the farms. a The CTX-M-27-producing E. coli was detected in faeces from a woman with no contact with pigs; at the same farm, CTX-M-1-producing E. coli was detected in a farmer and pigs.
b ESBL-producing E. coli isolates with the same ESBL type, phylotype, MLST type and PFGE type detected from both pigs and humans.
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was not detected in our study, but this enzyme has previously been detected in Danish pigs. 30 As in many other countries, the majority of the CTX-M-15-producing E. coli causing UTIs and bloodstream infections in humans belong to B2-ST131. 25, 31 None of the pig isolates in our study belonged to B2-ST131, but in vitro transfer of bla CTX-M-14 and bla CTX-M-15 of porcine origin to B2-ST131 has been shown. 30 In our study most bla CTX-M-1 genes were transferable by conjugation in vitro.
Our study shows that ESBL-producing E. coli are transferred between pigs and humans. Furthermore, pigs can be a reservoir for ESBL genes, which may be transferred to other E. coli that might be more pathogenic.
It seems likely that the CTX-M-1-, CTX-M-14-and CTX-M-27-producing E. coli detected in patients could be of animal origin, but further studies are needed to investigate and quantify a possible zoonotic link between ESBL-producing E. coli and human infections. ESBL-producing E. coli from Danish pigs and pig farmers
